Red blood cell background graphic

Do you have polycythemia vera (PV)?

You may be eligible to join ECLIPSE PV, a Phase 3b clinical research study in the US and Canada that is evaluating a new dosing regimen compared to the current recommended dosing regimen of an approved PV therapy. This therapy helps patients control increased blood counts (the number of red blood cells, white blood cells, and platelets) in the body more quickly.


For more information, contact our Medical Information team at

  • PharmaEssentia USA Corporation
  • 35 Corporate Drive, Suite 325,
  • Burlington, MA 01803, USA